Area of research
Nephrology · Critical Care and Intensive Care Medicine
Research interest
Dr. Parikh conducts an active patient-oriented research program investigating the translational and epidemiological aspects of acute kidney injury (AKI) and other kidney related disorders. His major research interest is developing novel biomarkers of AKI. He is the Principal Investigator of the NIH sponsored TRIBE-AKI consortium that is conducting large studies for validating novel kidney injury biomarkers in setting of cardiac surgery, kidney transplantation, diabetic kidney disease and hepatorenal syndrome. He has authored more than 250 peer-reviewed papers, 50 book chapters and reviews, and he has given more than 50 invited lectures at scientific meetings and academic institutions around the world.
Independent association between acute kidney injury and kidney function trajectory
Associations between exposure to polycyclic aromatic hydrocarbons and biomarkers of acute kidney injury among Chilean agricultural workers
Concordance of Pre-Biopsy and Post-Biopsy Diagnosis in Hospitalized Patients with Acute Kidney Injury.
Chronic Psychological Stress in Mice Induces Kidney Inflammation.
Kidney Biorepositories: Valuable Tools Advancing Acute Kidney Injury Research.
Associations of Blood Mitochondrial DNA Quality and Quantity with Risk of Kidney Function Decline.
Risk for Scrotal Surgery After Laparoscopic Donor Nephrectomy : A Population-Based Cohort Study.
Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure
Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study
Biomarker Panels for Discriminating Risk of CKD Progression in Children
Reversible compromise of physiological resilience by accumulation of heteroplasmic mtDNA mutations
Postdischarge Care of Acute Kidney Injury Survivors: An Opportunity for Targeted Nurse and Pharmacist Interventions
Kidney Transplant Outcomes From Deceased Donors Who Received Dialysis
An atlas of healthy and injured cell states and niches in the human kidney
Longitudinal biomarkers and kidney disease progression after acute kidney injury
A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes
The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events
Integrated Analysis of Blood and Urine Biomarkers to Identify Acute Kidney Injury Subphenotypes and Associations With Long-term Outcomes
Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial
Joint Modeling of Clinical and Biomarker Data in Acute Kidney Injury Defines Unique Subphenotypes with Differing Outcomes
Genome-wide Association Study for AKI
Urinary Biomarkers of Kidney Tubule Health and Mortality in Persons with CKD and Diabetes Mellitus
Associations of Biomarkers of Kidney Tubule Health, Injury, and Inflammation with Left Ventricular Hypertrophy in Children with CKD
Plasma Biomarkers and Incident CKD Among Individuals Without Diabetes
Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
Considerations in Controlling for Urine Concentration for Biomarkers of Kidney Disease Progression After Acute Kidney Injury
Untargeted metabolomics of perfusate and their association with hypothermic machine perfusion and allograft failure
Plasma Biomarkers as Risk Factors for Incident CKD